<?xml version="1.0" encoding="UTF-8"?>
<p>In both ruminants and monogastrics, identifying immunomodulatory molecules for bovine mastitis, or calf, pig, and chicken intestinal diseases, is a promising alternative strategy to using antibiotics that may result in resistance development in humans and animals. Although there is a growing interest in the use of EOs, few data are available on the degradation rate of EOs and their compounds in the gastrointestinal tract and the way they are prepared and fed to animals, e.g., whether they are micro-encapsulated or not [
 <xref rid="B129-antioxidants-10-00330" ref-type="bibr">129</xref>].
</p>
